Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 23 Apr 2023
The treatment of chronic thromboembolic pulmonary hypertension with balloon pulmonary angioplasty has an evolving safety profile over the years, from 2013 to 2022, as revealed by an analysis of more than two dozen studies.
Read Full NewsOlder adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.
A retrospective study suggests a high burden of prolonged, mostly low-grade infections in patients with multiple myeloma who receive T-cell-engaging therapies.
A national cohort study compares the safety and efficacy of weight-based and fixed-dose pembrolizumab regimens in patients with advanced non-small cell lung cancer.
Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.
1.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
2.
Inner Thoughts of Leonard Bernstein, the "Maestro".
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
5.
BlurryScope: A compact, AI-powered microscope for rapid, cost-effective cancer scoring
1.
Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms
2.
Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy
3.
Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges
4.
The Complications and Treatments of Intraosseous Hemangioma - A Comprehensive Guide
5.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
4.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
5.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge